Randomized Fase II Trial: Comparing Cisplatin, Paclitaxel and Gemcitabine Versus Cisplatin, Paclitaxel, Gemcitabine and Avastin in Patients With Unknown Primary Tumors.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 01 Nov 2012
At a glance
- Drugs Bevacizumab (Primary) ; Cisplatin; Gemcitabine; Paclitaxel
- Indications Solid tumours
- Focus Therapeutic Use
- 29 Sep 2009 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 18 Apr 2007 New trial record.